平特五不中 researchers discover gene that increases susceptibility to Crohn's disease
"Broken" bacterial sensor doesn鈥檛 detect harmful bacteria in the digestive system
Researchers at 平特五不中, the Research Institute of the 平特五不中 Health Centre (RI MUHC) and the 平特五不中 and G茅nome Qu茅bec Innovation Centre, along with colleagues at other Canadian and Belgian institutions, have discovered DNA variations in a gene that increases susceptibility to developing Crohn鈥檚 disease. Their study was published in the January issue of the journal Nature Genetics .
The study was led by 平特五不中 PhD candidate Alexandra-Chlo茅 Villani under the supervision of Dr. Denis Franchimont and Dr. Thomas Hudson. Dr. Franchimont, now with the Erasme Hospital in Brussels, Belgium, was a Canada Research Chair formerly affiliated with the Gastroenterology Dept. of the MUHC. Dr. Hudson, former Director of the 平特五不中 and G茅nome Qu茅bec Innovation Centre, is now the President and Scientific Director of the Ontario Institute for Cancer Research (OICR), located in Toronto.
The researchers pinpointed DNA sequence variants in a gene region called NLRP3 that are associated with increased susceptibility to Crohn鈥檚 disease. Crohn鈥檚 is a chronic relapsing inflammatory disease of the digestive system that can affect any part of the gastrointestinal tract. Patients can suffer from a number of different symptoms in various combinations, including abdominal pain, bloody diarrhea, fever, vomiting and weight loss. Rarer complications include skin manifestations, arthritis and eye inflammation.
"Although the exact cause of Crohn鈥檚 disease is still unknown, both environmental and genetic factors are known to play a critical role in the pathogenesis of the disease," Dr. Franchimont said.
Crohn鈥檚 disease is found throughout the world. However, it appears to be most common in North America and northern Europe, and Canada has one of the highest incidence rates in the world. Crohn鈥檚 affects between 400,000 and 600,000 people in North America .
The 400 square metres of the intestinal absorptive area is the largest single surface in or on the human body, and it is covered by billions of bacteria of the intestinal microflora living in the gastrointestinal tract.
"The single layer of cells lining your intestinal digestive tract is thus constantly exposed to high levels of bacteria and pathogens," Villani explained. "These cells must recognize and respond appropriately to the harmful bacteria while maintaining tolerance to the non-pathogenic 鈥榞ood鈥� bacteria that make up your intestinal microbial flora. This is the central challenge of the digestive immune system, which needs to balance defence versus tolerance."
"The protein encoded by the Crohn鈥檚 disease susceptibility gene NLRP3, cryopyrin, is an intracellular bacteria sensor that plays a key role in initiating immune response," explained Villani. Based on their results, researchers theorize the bacterial sensor cryopyrin is probably defective in some patients, and doesn鈥檛 correctly recognize the presence of harmful bacteria.
"When the digestive immune system鈥檚 counter-attack is insufficient to clear the threat," Ms. Villani continued,"there is a bacterial infiltration in the intestinal wall through the first line of defence mechanisms. The digestive immune system will again try to repel the threat, but the effort may not be sufficient, and this usually leads to a vicious cycle that results in chronic inflammation in the intestinal wall. And that is Crohn鈥檚 disease."
"This gene also plays a central role in the regulation of fever, which is one of the most primitive defence mechanisms that exists in humans to fight the surrounding pathogenic bacteria," Dr. Hudson added. " DNA sequence variations in the NLRP3 gene are also known to be responsible for hereditary periodic fever syndromes."
"Previously published genome-wide association studies have already detected more than 30 distinct Crohn鈥檚 genetic factors, but these only explain about one-fifth of Crohn鈥檚 disease heritability", said Dr. Franchimont.
Though these results will not lead to any new short-term treatments for Crohn鈥檚, Dr. Franchimont is confident that in the longer term it will benefit patient care. "Studies like this one give us a better understanding of key pathways and pathogenic mechanisms involved in Crohn鈥檚 disease," he said. "Now that we are aware of the role of bacterial sensors in the disease, steps can be taken to develop a new treatment strategy."
The study was supported by grants from the Canada Foundation for Innovation, the Canada Research Chair program, the Research Institute of the 平特五不中 Health Centre and the Crohn鈥檚 & Colitis Foundation of Canada (CCFC).
ABOUT McGILL UNIVERSITY
平特五不中, founded in Montreal, Que., in 1821, is Canada鈥檚 leading post-secondary institution. It has two campuses, 11 faculties, 10 professional schools, 300 programs of study and more than 33,000 students. 平特五不中 attracts students from more than 160 countries around the world. Almost half of 平特五不中 students claim a first language other than English 鈥� including 6,000 francophones 鈥� with more than 6,200 international students making up almost 20 per cent of the student body.
ABOUT THE RESEARCH INSTITUTE OF THE McGILLUNIVERSITY HEALTH CENTRE (RI MUHC)
The RI MUHC is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the MUHC, the University Health Centre affiliated with the Faculty of Medicine at 平特五不中 University. The Institute supports more than 600 researchers, nearly 1,200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. The Research Institute of the MUHC is supported in part by the Fonds de la recherche en sant茅 du Qu茅bec. For further details visit:
ABOUT THE McGILL UNIVERSITY AND G脡NOME QU脡BEC INNOVATION CENTRE
The 平特五不中 and G茅nome Qu茅bec Innovation Centre is financed by Genome Canada and the minist猫re du D茅veloppement 脡conomique, de l鈥橧nnovation et de l鈥橢xportation of Qu茅bec, and provides complete DNA analysis services, from a few samples to several tens of thousands per week. Ambitious DNAsequencing projects carried out over the past five years are testimony of G茅nome Qu茅bec鈥檚 ability to provide data of exceptional quality in the pursuit of various genomics studies. Large-scale genomics projects at the Innovation Centre are highly integrated together on three platforms: sequencing, genotyping and functional genomics supported by an infrastructure and unique expertise in bioinformatics. High-quality protein separation and analysis services are also provided by the proteomics platform. To find out more, visit their Web site at .
ABOUT THE ONTARIO INSTITUTE FOR CANCER RESEARCH
OICR is a centre of excellence, moving Ontario to the forefront of discovery and innovation. It is dedicated to research in prevention, early detection, diagnosis, treatment and control of cancer. OICR is a not-for-profit corporation funded by the Government of Ontario through the Ministry of Research and Innovation. For more information, please visit the website at .